Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
53 Cards in this Set
- Front
- Back
|
Desipramine
|
TCA
|
|
|
nortriptyline
|
TCA
|
|
|
amitriptyline
|
TCA
|
|
|
amitriptyline
|
TCA
|
|
|
protriptyline
|
TCA
|
|
|
trimipramine
|
TCA
|
|
|
TCA MOA
|
Reuptake inhibitors of NE and 5-ht
Antidepressant |
|
|
tranylcypromine
|
MAOI
|
|
|
isocarboxazid
|
MAOI
|
|
|
phenelzine
|
MAOI
|
|
|
MAOI MOA
|
inhibit breakdown of monoamines
Antidepressant |
|
|
fluoxetine
|
SSRI
|
|
|
sertraline
|
SSRI
|
|
|
paroxetine
|
SSRI
|
|
|
citalopram
|
SSRI
|
|
|
escitalopram
|
SSRI
|
|
|
fluvoxamine
|
SSRI
|
|
|
SSRI MOA
|
Selectively blocks 5-ht reuptake
Antidepressant |
|
|
duloxetine
|
SNRI
|
|
|
venlafaxine
|
SNRI
|
|
|
SNRI MOA
|
reuptake inhibitor of 5ht and NE
Antidepressant |
|
|
Trazodone MOA
|
5HT reuptake inhibitor and 5HT antagonist
Antidepressant |
|
|
Nefazadone MOA
|
5HT reuptake blocker
Antidepressant |
|
|
Mirtazapine MOA
|
a2 antagonist, 5HT antagonist, and H1 antagonist
Antidepressant |
|
|
Lithium MOA
|
Alters cation transport across cell membrane in nerve and muscle cells and influences reuptake of 5HT and NE.
Bipolar disorder |
|
|
Chlorpromazine
|
aliphatic phenothiazine typical antipsychotic
|
|
|
Thioridazine
|
piperidine phenothiazine typical antipsychotic
|
|
|
Fluphenazine
|
piperazine phenothiazine typical antipsychotic
|
|
|
Thiothixene
|
thioxanthine typical antipsychotic
|
|
|
Haloperidol
|
butyrophenone typical antipsychotic
|
|
|
clozapine MOA
|
D4, 5HT2A, and D2 receptor blocker
Atypical antipsychotic |
|
|
risperidone
|
Atypical antipsychotic
|
|
|
aripiprazole MOA
|
partial DA agonist for D2 and D3 receptors
Atypical antipsychotic |
|
|
ziprasidone
|
Atypical antipsychotic
|
|
|
quetiapine
|
Atypical antipsychotic
|
|
|
olanzapine
|
Atypical antipsychotic
|
|
|
Typical antipsychotic MOA
|
D2 receptor blocker
|
|
|
Atypical antipsychotic MOA
|
5HT2A and D2 receptor blocker
|
|
|
Carbidopa MOA
|
peripheral AADC inhibitor
Parkinson's disease |
|
|
L-DOPA MOA
|
protein precursor to DA
Parkinson's disease |
|
|
Apomorphine MOA
|
dopamine agonist
Parkinson's disease |
|
|
Bromocriptine MOA
|
DA agonist
Parkinson's disease |
|
|
Pramipexole MOA
|
D3 agonist
Parkinson's disease |
|
|
Ropinirole MOA
|
D2 agonist
Parkinson's disease |
|
|
Tolcapone MOA
|
COMT inhibitor
Parkinson's disease |
|
|
Entacapone MOA
|
COMT inhibitor
Parkinson's disease |
|
|
Selegiline MOA
|
MAO-B inhibitor
Parkinson's disease |
|
|
Rasagiline MOA
|
MAO-B inhibitor
Parkinson's disease |
|
|
Amantadine MOA
|
stimulates DA release and inhibits DA reuptake
Parkinson's disease |
|
|
Benztropine MOA
|
anticholinergic agent used in Parkinson's and antipsychotic therapy
|
|
|
Trihexyphenidyl MOA
|
anticholinergic agent used in Parkinson's and antipsychotic therapy
|
|
|
AADC
|
decarboxylates L-DOPA to DA in periphery and brain
|
|
|
COMT
|
enzyme that metabolizes L-DOPA and DA
|
